1 / 7

Daily Equity Report 14 march, 2018

Research Panel is Indiau2019s one of the best stock advisory who caters & delivers the best stock recommendation in Equity Market & Commodity Market. We give Constant advice for letting your money to flow in the right direction.

researchpanel20
Download Presentation

Daily Equity Report 14 march, 2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESEARCH PANEL INVESTMENT ADVISERS EQUITY REPORT 14/MARCH/2019 WWW.RESEARCHPANEL.CO.IN SEBI REGN NO. INA000005390

  2. Research Panel Investment THE DOMESTIC EQUITY MARKET HAD A POSITIVE CLOSE ON TUESDAY WITH SENSEX ENDING OVER 200 POINTS, POWERED BY FINANCIALS AND ENERGY STOCKS.THE S&P BSE SENSEX REMAINED RANGEBOUND FOR MOST OF THE DAY BUT ENJOYED A LATE SURGE TO END AT 37,752.17, UP 216.5 POINTS OR 0.58 PER CENT. BLUE-CHIPS LIKE INDUSIND BANK, YES BANK, RELIANCE AND AXIS BANK WERE AMONG THE CHIEF CONTRIBUTORS. THE 50- SHARE INDEX NIFTY OF THE NATIONAL STOCK EXCHANGE (NSE) HAD A HUMBLER DAY BUT STILL ADDED 40.50 POINTS OR 0.36 PER CENT TO CLOSE AT 11,341.70.AMONG INDIVIDUAL STOCKS, HDFC BANK ZOOMED OVER 2.5% TO END AT 2,226.10 ON THE BACK OF HEAVY VOLUMES.ON THE OTHER HAND, SPICEJET SLIPPED MORE THAN 2 PER CENT TO RS 77.15 AFTER THE DIRECTORATE GENERAL OF CIVIL AVIATION (DGCA), INDIA’S AVIATION REGULATOR, GROUNDED BOEING 737 MAX PLANES FOLLOWING THE FATAL CRASH OF A PLANE OF THE SAME MODEL IN ETHIOPIA THAT KILLED 157 PEOPLE.AMONG SECTORAL INDICES, THE NIFTY BANK INDEX GAINED 1.64 PER CENT HIGHER WITH INDUSIND BANK AND YES BANK BEING THE TOP GAINERS. THE NIFTY PSU BANK INDEX ALSO CLIMBED NEARLY 1.64 PER CENT LED BY GAINS IN CANARA BANK AND J&K BANK.IN THE BROADER MARKET, THE S&P BSE MIDCAP INDEX ENDED 64.91 POINTS, OR 0.43 PER CENT LOWER AT 15,127.93, WHILE THE S&P BSE SMALLCAP INDEX ENDED AT 14,874.69, DOWN 45.81, OR 0.31 PER CENT. GLOBAL MARKET INDEX NASDAQ FTSE CAC 40 HANG SENG CMP 7591.03 7180.48 5294.71 28807.45 % CHANGE 0.44 0.41 0.46 -0.39 NSE GAINER COMPANY NAME INDUSINDBK YESBANK BAJFINANCE HDFCBANK SBIN CMP PREV. CLOSE CHANGE % 1636.90 244.25 2832.00 2229.00 293.85 1569.05 235.85 2753.05 2171.00 286.90 4.32 3.56 2.87 2.67 2.42 NSE LOSERS COMPANY NAME BHARTIARTEL IOC ZEEL SUNPHARMA VEDL CMP PREV. CLOSE CHANGE % 336.75 148.45 447.80 455.60 172.00 351.80 154.10 463.60 470.30 178.45 -4.28 -3.67 -3.41 -3.13 -2.60

  3. Research Panel Investment SECTORIAL INDICES INDEX NIFTY 50 NIFTY NEXT 50 NIFTY 100 NIFTY 200 NIFTY 500 NIFTY MIDCAP 100 NIFTY BANK NIFTY AUTO NIFTY FIN SERVICE NIFTY FMCG NIFTY IT NIFTY PHARMA CLOSE PR CLOSE % CHANGE 11341.70 11301.20 0.36 28047.85 28208.30 -0.57 11527.20 11499.95 0.24 5940.25 5931.60 0.15 9450.25 9440.85 0.10 17733.45 17831.95 -0.55 28884.30 28443.70 1.55 8767.55 8802.90 -0.40 12034.15 11895.45 1.17 30451.60 30480.80 -0.10 15342.90 15384.55 -0.27 9100.25 9274.80 -1.88 FII/DII INVESTMENTS CATEGORY FII/FPI DII DATE 13/MARCH/2019 13/MARCH/2019 BUY VALUE 8602.7 3332.87 SELL VALUE 5880.42 4841.01 NET VALUE 2722.28 -1508.14

  4. Research Panel Investment PIVOT NIFTY SCRIPT R4 R3 R2 R1 P S1 S2 S3 S4 NIFTY 12151 11863 11575 11474 11287 11186 11000 10712 10424 POINT OF VIEW TREND: BULLISH RESISTANCE: 11380, 11460 SUPPORT: 11100, 11120 STRATEGY: BUY ON DIP

  5. Research Panel Investment PIVOT BANK NIFTY SCRIPT R4 R3 R2 R1 P S1 S2 S3 S4 NIFTY 30481 29919 29357 29153 28795 28591 28232 27670 27108 POINT OF VIEW TREND: BULLISH RESISTANCE: 29000, 29180 SUPPORT: 28430, 28250 STRATEG: BUY ON DIP

  6. Research Panel Investment STOCK OF THE DAY:- PIDILITIND FUTURE:- TECHNICAL VIEW:- BULLISH MARUBOZU PATTERN FOUND IN CHART WITH VOLUME EXPANSION THERE FORE WE RECOMMEND BUY PIDILITIND FUTURE ABOVE 1188 TGT 1208 SL 1168.

  7. Research Panel Investment DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Research Panel Investment does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Research Panel Investment might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved.

More Related